Global Pharma Participates in InWECNA Conference 2026

7-8 February 2026 · Jakarta, Indonesia

Global Pharma Participates in InWECNA Conference 2026

An International Forum for Wound, Ostomy, and Continence Care

Global Pharma participated in The 5th International and 9th Biennial Conference of the Indonesian Wound, Enterostomal, and Continence Nurses Association, known as InWECNA Conference 2026.

The event took place in Jakarta on 7–8 February 2026 and brought together nurses, healthcare professionals, researchers, academics, students, healthcare institutions, and industry stakeholders.

Its central focus was the continued development of wound, ostomy, and continence management through professional empowerment, evidence-based practice, education, and collaboration.

Wounds, stomas, and continence conditions can affect many aspects of a patient’s life.

In addition to physical symptoms, patients may experience emotional distress, reduced confidence, social limitations, difficulty working, or dependence on caregivers.

High-quality care therefore requires more than technical treatment. Professionals must also consider education, dignity, comfort, daily function, and long-term quality of life.

Conferences such as InWECNA help bring these dimensions together.

Professional conferences allow participants to compare experiences, discuss research, review clinical developments, and consider new approaches.

Evidence-based practice combines research findings, clinical expertise, patient needs, and available resources.

This approach is especially important in wound, ostomy, and continence care because treatment decisions often need to be individualized.

Global Pharma supports the responsible use of healthcare products within this broader clinical framework.

Industry participation in healthcare conferences should create value for clinical professionals.

Global Pharma used the event to communicate with nurses, wound-care specialists, researchers, educators, healthcare managers, and other participants.

These conversations helped the company understand current challenges, product expectations, education needs, and service requirements.

They also supported more informed communication between healthcare providers and solution suppliers.

Healthcare professionals need opportunities to strengthen their knowledge and confidence.

Education may support improved assessment, more appropriate product use, stronger patient communication, and better continuity of care.

Global Pharma’s participation reflected its commitment to supporting these professional-development objectives.

The company believes that reliable healthcare solutions are most effective when users also receive clear information and appropriate support.

Better outcomes are not measured only by clinical improvement.

For a patient with a wound, stoma, or continence condition, success may also mean reduced discomfort, greater independence, improved mobility, restored confidence, and the ability to resume daily activities.

A patient-centered approach recognizes these broader goals.

Global Pharma supports collaboration that places patient needs at the center of healthcare decision-making.